Adherence to FDA Guidance on Pulse Oximetry Testing Among Diverse Individuals, 1996-2024

Kadija Ferryman; Deidra C Crews; Emmanuel F Drabo; Theodore J Iwashyna; Odia Kane; John W Jackson

doi:10.1001/jama.2024.26473

Adherence to FDA Guidance on Pulse Oximetry Testing Among Diverse Individuals, 1996-2024

JAMA. 2024 Dec 30. doi: 10.1001/jama.2024.26473. Online ahead of print.

Authors

Kadija Ferryman^{1

2}, Deidra C Crews^{2

3}, Emmanuel F Drabo², Theodore J Iwashyna^{2

3}, Odia Kane^{1

2}, John W Jackson²

Affiliations

¹ Berman Institute of Bioethics, Johns Hopkins University, Baltimore, Maryland.
² Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland.
³ School of Medicine, Johns Hopkins University, Baltimore, Maryland.

PMID: 39786431
DOI: 10.1001/jama.2024.26473

No abstract available

Plain language summary

This study examines temporal trends in US Food and Drug Administration clearance summaries for pulse oximeters that report information about race and ethnicity and/or skin color or tone.